Diet/exercise programs are used by only one in five severely obese patients with biopsy-defined Nonalcoholic Fatty Liver Disease (NAFLD) advanced fibrosis in the Veterans Health Administration (VHA)
Publication
, Conference
Patel, YA; Gifford, E; Glass, LM; McNeil, R; Turner, MJ; Han, B; Provenzale, DT; Choi, SS; Moylan, CA; Hunt, CM
Published in: HEPATOLOGY
October 1, 2017
Duke Scholars
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
October 1, 2017
Volume
66
Start / End Page
1164A / 1164A
Location
Washington, DC
Publisher
WILEY
Conference Name
68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Patel, Y. A., Gifford, E., Glass, L. M., McNeil, R., Turner, M. J., Han, B., … Hunt, C. M. (2017). Diet/exercise programs are used by only one in five severely obese patients with biopsy-defined Nonalcoholic Fatty Liver Disease (NAFLD) advanced fibrosis in the Veterans Health Administration (VHA). In HEPATOLOGY (Vol. 66, pp. 1164A-1164A). Washington, DC: WILEY.
Patel, Yuval A., Elizabeth Gifford, Lisa M. Glass, Rebecca McNeil, Marsha J. Turner, Byungjoo Han, Dawn T. Provenzale, Steve S. Choi, Cynthia A. Moylan, and Christine M. Hunt. “Diet/exercise programs are used by only one in five severely obese patients with biopsy-defined Nonalcoholic Fatty Liver Disease (NAFLD) advanced fibrosis in the Veterans Health Administration (VHA).” In HEPATOLOGY, 66:1164A-1164A. WILEY, 2017.
Patel YA, Gifford E, Glass LM, McNeil R, Turner MJ, Han B, et al. Diet/exercise programs are used by only one in five severely obese patients with biopsy-defined Nonalcoholic Fatty Liver Disease (NAFLD) advanced fibrosis in the Veterans Health Administration (VHA). In: HEPATOLOGY. WILEY; 2017. p. 1164A-1164A.
Patel, Yuval A., et al. “Diet/exercise programs are used by only one in five severely obese patients with biopsy-defined Nonalcoholic Fatty Liver Disease (NAFLD) advanced fibrosis in the Veterans Health Administration (VHA).” HEPATOLOGY, vol. 66, WILEY, 2017, pp. 1164A-1164A.
Patel YA, Gifford E, Glass LM, McNeil R, Turner MJ, Han B, Provenzale DT, Choi SS, Moylan CA, Hunt CM. Diet/exercise programs are used by only one in five severely obese patients with biopsy-defined Nonalcoholic Fatty Liver Disease (NAFLD) advanced fibrosis in the Veterans Health Administration (VHA). HEPATOLOGY. WILEY; 2017. p. 1164A-1164A.
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
October 1, 2017
Volume
66
Start / End Page
1164A / 1164A
Location
Washington, DC
Publisher
WILEY
Conference Name
68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics